Federated Hermes’s Enzo Biochem, Inc. ENZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-132
| Closed | -$189 | – | 2287 |
|
|
2022
Q4 | $189 | Hold |
132
| – | – | ﹤0.01% | 2121 |
|
|
2022
Q3 | $1K | Hold |
132
| – | – | ﹤0.01% | 2097 |
|
|
2022
Q2 | $1K | Sell |
132
-94
| -42% | -$232 | ﹤0.01% | 2102 |
|
|
2022
Q1 | $1K | Hold |
226
| – | – | ﹤0.01% | 2132 |
|
|
2021
Q4 | $1K | Hold |
226
| – | – | ﹤0.01% | 2165 |
|
|
2021
Q3 | $1K | Hold |
226
| – | – | ﹤0.01% | 2172 |
|
|
2021
Q2 | $1K | Hold |
226
| – | – | ﹤0.01% | 2168 |
|
|
2021
Q1 | $1K | Sell |
226
-8
| -3% | -$25 | ﹤0.01% | 2198 |
|
|
2020
Q4 | $1K | Sell |
234
-42
| -15% | -$91 | ﹤0.01% | 2196 |
|
|
2020
Q3 | $1K | Sell |
276
-6
| -2% | -$14 | ﹤0.01% | 2207 |
|
|
2020
Q2 | $1K | Sell |
282
-15
| -5% | -$39 | ﹤0.01% | 2184 |
|
|
2020
Q1 | $1K | Hold |
297
| – | – | ﹤0.01% | 2166 |
|
|
2019
Q4 | $1K | Hold |
297
| – | – | ﹤0.01% | 2157 |
|
|
2019
Q3 | $1K | Hold |
297
| – | – | ﹤0.01% | 2142 |
|
|
2019
Q2 | $1K | Sell |
297
-8
| -3% | -$28 | ﹤0.01% | 2128 |
|
|
2019
Q1 | $1K | Hold |
305
| – | – | ﹤0.01% | 2117 |
|
|
2018
Q4 | $1K | Sell |
305
-762
| -71% | -$2.5K | ﹤0.01% | 2150 |
|
|
2018
Q3 | $4K | Sell |
1,067
-602
| -36% | -$2.73K | ﹤0.01% | 2094 |
|
|
2018
Q2 | $9K | Sell |
1,669
-15,156
| -90% | -$92.3K | ﹤0.01% | 1930 |
|
|
2018
Q1 | $92K | Sell |
16,825
-141,255
| -89% | -$995K | ﹤0.01% | 1602 |
|
|
2017
Q4 | $1.29M | Buy |
158,080
+426
| +0.3% | +$4.07K | ﹤0.01% | 1124 |
|
|
2017
Q3 | $1.65M | Buy |
157,654
+38,648
| +32% | +$429K | ﹤0.01% | 1003 |
|
|
2017
Q2 | $1.31M | Buy |
119,006
+9,762
| +9% | +$91K | ﹤0.01% | 1113 |
|
|
2017
Q1 | $914K | Buy |
109,244
+107,800
| +7,465% | +$759K | ﹤0.01% | 1202 |
|
|
2016
Q4 | $10K | Sell |
1,444
-447
| -24% | -$2.85K | ﹤0.01% | 1833 |
|
|
2016
Q3 | $10K | Buy |
1,891
+267
| +16% | +$1.59K | ﹤0.01% | 1827 |
|
|
2016
Q2 | $10K | Buy |
1,624
+887
| +120% | +$4.92K | ﹤0.01% | 1815 |
|
|
2016
Q1 | $3K | Hold |
737
| – | – | ﹤0.01% | 1952 |
|
|
2015
Q4 | $3K | Buy |
737
+365
| +98% | +$1.54K | ﹤0.01% | 1939 |
|
|
2015
Q3 | $1K | Sell |
372
-231
| -38% | -$701 | ﹤0.01% | 1922 |
|
|
2015
Q2 | $2K | Hold |
603
| – | – | ﹤0.01% | 1877 |
|
|
2015
Q1 | $2K | Buy |
+603
| New | +$1.97K | ﹤0.01% | 1951 |
|
|
2014
Q4 | – | Sell |
-1,359
| Closed | -$7K | – | 2059 |
|
|
2014
Q3 | $7K | Sell |
1,359
-157
| -10% | -$838 | ﹤0.01% | 1793 |
|
|
2014
Q2 | $8K | Buy |
+1,516
| New | +$6.55K | ﹤0.01% | 1765 |
|
Other funds holding ENZ
MFS
HFA
TCM
RAM
PCM
Federated Hermes's ENZ Position: Q1 2023 in Review
Federated Hermes sold out of Enzo Biochem, Inc. (ENZ) in Q1 2023, closing a stake of 132 shares — an estimated $189 sold.
Federated Hermes first reported a position in ENZ in Q2 2014 and held it in 34 quarters. The position peaked at $1.65M in Q3 2017. 52 funds tracked by Wall St. Rank hold ENZ as of Q1 2023.
- Federated Hermes reported no remaining Enzo Biochem, Inc. position as of Q1 2023 after selling out during the quarter.
- Federated Hermes sold 132 Enzo Biochem, Inc. shares in Q1 2023, an estimated $189.
- Federated Hermes first reported a position in Enzo Biochem, Inc. in Q2 2014 and held it in 34 quarters.
- Federated Hermes's Enzo Biochem, Inc. position peaked at $1.65M in Q3 2017.
- 52 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q1 2023.
Based on Federated Hermes's 13F filing for Q1 2023, filed 8 May 2023.